Marine Organisms as Potential Sources of Bioactive Peptides that Inhibit the Activity of Angiotensin I-Converting Enzyme: A Review

Molecules. 2019 Jul 12;24(14):2541. doi: 10.3390/molecules24142541.

Abstract

Angiotensin I-converting enzyme (ACE) is a paramount therapeutic target to treat hypertension. ACE inhibitory peptides derived from food protein sources are regarded as safer alternatives to synthetic antihypertensive drugs for treating hypertension. Recently, marine organisms have started being pursued as sources of potential ACE inhibitory peptides. Marine organisms such as fish, shellfish, seaweed, microalgae, molluscs, crustaceans, and cephalopods are rich sources of bioactive compounds because of their high-value metabolites with specific activities and promising health benefits. This review aims to summarize the studies on peptides from different marine organisms and focus on the potential ability of these peptides to inhibit ACE activity.

Keywords: ACE inhibitory peptide; antihypertensive; bioactive peptides; hypertension; marine resources.

Publication types

  • Review

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / chemistry
  • Angiotensin-Converting Enzyme Inhibitors / metabolism
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology*
  • Antihypertensive Agents / metabolism
  • Antihypertensive Agents / pharmacology
  • Aquatic Organisms / metabolism*
  • Biological Products / metabolism
  • Biological Products / pharmacology
  • Biomarkers
  • Dose-Response Relationship, Drug
  • Drug Discovery
  • Drug Evaluation, Preclinical
  • Peptide Biosynthesis*
  • Peptides / chemistry
  • Peptides / metabolism*
  • Peptides / pharmacology*

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Antihypertensive Agents
  • Biological Products
  • Biomarkers
  • Peptides

Grants and funding